Author: user

Investing.com –Rosenblatt Securities initiated coverage of MongoDB (NASDAQ:) with a buy rating and a $350 price target, on strong growth opportunities in the database market and AI-driven applications. The brokerage sees MongoDB as a leading provider of NoSQL databases, set to benefit from the ongoing migration away from legacy systems. Rosenblatt analyst noted that recent weakness in MongoDB’s stock but views the current levels as attractive for long-term investors. “With the stock’s recent weakness on what we view as mostly misunderstandings,” analyst wrote. For Rubrik Inc (NYSE:), Rosenblatt started coverage with a neutral rating and a $77 price target. The…

Read More

Investing.com — Honda (NYSE:) Motor and Nissan (OTC:) Motor are set to engage in discussions regarding a potential merger, aiming to pool resources to strengthen their position in the electric vehicle market, according to on Wednesday. The two Japanese automakers are contemplating the possibility of operating under a shared holding company, the report said, adding that a memorandum of understanding, which will formally initiate these negotiations, is expected to be signed shortly. Details regarding their respective stakes in the newly proposed entity, along with other specifics, will be determined at a later stage, the report said. This move signifies a…

Read More

Sign up for free to read a limited number of articles each month.Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS NEWS Daily at 11:30 AM ET EARLY EDITION Daily at 7:15 AM ET ENDPOINTS PHARMA Daily at 3:30 PM ET BREAKING NEWS ALERTS 2-3 times a week ENDPOINTS FDA+ Wed at 2 PM ET ENDPOINTS MANUFACTURING Thu at 2 PM ET ENDPOINTS WEEKLY Sat at 6 AM ET POST-HOC 1-2 times a week Healthcare ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET BREAKING NEWS ALERTS 2-3 times a week Source link

Read More

Investors are growing increasingly bullish as the stock market rally rolls on to end 2024. In Bank of America’s December Global Fund Manager Survey, 36% of respondents said they’re overweight US equities, the highest level seen in the survey’s history. This large shift into US stocks came alongside a record-low allocation to cash and a three-year high in global risk appetite. It also falls in line with recent calls across Wall Street for US “exceptionalism” to continue in 2025. Bank of America investment strategist Michael Hartnett noted that excitement about Donald Trump’s second-term, optimism surrounding growth in the US, and…

Read More

By Jennifer Rigby LONDON (Reuters) – A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday. The ambition is to start deliveries of Gilead (NASDAQ:) Sciences’ lenacapavir on that timeline, said Hui Yang, head of supply operations at the Global Fund to Fight AIDS, Tuberculosis and Malaria. However, she said a lot of things need to happen first, including the injectable drug receiving regulatory approvals from authorities like the United States Food and Drug Administration and the World Health Organization. Lenacapavir is…

Read More

Nvidia (NVDA) stock continued to slide on Tuesday after shares fell more than 10% from a November record close. The chip giant’s stock dropped nearly 3% in early trade before bouncing off of its session lows. The moves echoed a decline across all three major indexes, which have taken a breather as investors debate what could happen to the US economy in 2025. “This rally, which has been really dramatic since July, is starting to look a little bit vulnerable,” James Demmert, chief investment officer at Main Street Research, told Yahoo Finance’s Morning Brief. “So going into 2025, I think…

Read More

Former director of the US Office of Trade and Manufacturing Policy Peter Navarro speaks on stage with his “Wife Bonnie” on the third day of the Republican National Convention at the Fiserv Forum on July 17, 2024 in Milwaukee, Wisconsin. Chip Somodevilla | Getty ImagesPeter Navarro, who is set to become the top trade advisor to President-elect Donald Trump, contended Tuesday that Trump’s plans for broad tariffs and steep tax cuts will not spur inflation or raise deficits, despite warnings from some experts.Navarro said Trump’s first term in the White House proved his point.”We put on significant tariffs on China, steel,…

Read More

Image source: Getty Images UK shares often gets a bad rap for lacking innovation and growth potential. But Schroder UK Mid Cap fund manager Jean Roche begs to differ. She argues that investors have a better chance of unearthing top-performing ‘multibagger’ stocks — companies that surge more than 100% — right here in Britain. Roche’s points to the impressive success stories of several UK-listed companies that have delivered exceptional returns for shareholders, including Cranswick, Halma, Diploma, Games Workshop, 4Imprint, Ashtead Group, and JD Sports. These companies have not only thrived but have become multibaggers, delivering returns several times the original…

Read More

If there was a Wild West in Private Equity (PE), it would be the Lower Middle Market (LMM) — the ecosystem of companies with revenues between $5 million and $50 million. The LMM offers lucrative opportunities but comes with unique risks that can derail even the most promising deals. For investment professionals, navigating this space requires a deep understanding of agency risk, an often-overlooked challenge stemming from the reliance on underqualified intermediaries and inexperienced sellers. Companies at this end of the market can vary greatly in terms of management quality, company infrastructure, and economic viability (post change of control). In…

Read More